1. Perini, P, Nabulsi, B, Massoni, CB, Azzarone, M, Freyrie, A. Acute limb ischemia in two young, non-atherosclerotic patients with COVID-19. The Lancet. 2020;395(10236):1546.
Google Scholar | Crossref | Medline2. World Health Organization . Coronavirus disease 2019 (COVID-19) situation report–51. World Health Organization; 2020. https://www.who.int/docs/default-source/coronaviruse/situationreports/ 20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_10
Google Scholar3. https://www.worldometers.info/coronavirus/ (08/06/2021)
Google Scholar4. https://covid19.saglik.gov.tr/(08/06/2021)
Google Scholar5. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html (08/06/2021)
Google Scholar6. Singhal, T . A review of coronavirus disease-2019 (COVID-19). The Indian Journal of Pediatrics. 2020;87(4):281–286.
Google Scholar | Crossref7. Mao, L, Jin, H, Wang, M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690.
Google Scholar | Crossref8. Farina, M, Barbisoni, F, Bertacchini, S, et al. An account of the first hours of the covid-19 epidemic at the nephrology unit in lodi (Lombardy). GiornaleItaliano di Nefrologia: OrganoUfficiale Della SocietaItaliana di Nefrologia. 2020;37(2).
Google Scholar9. Han, H, Yang, L, Liu, R, et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;1(ahead-of-print).
Google Scholar10. Bikdeli, B, Madhavan, MV, Jimenez, D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up. J Am Coll Cardiol. 2020;75(23):2950–2973.
Google Scholar | Crossref11. Tang, N, Bai, H, Chen, X, Gong, J, Li, D, Sun, Z. Anticoagulanttreatment is associatedwithdecreasedmortality in severe coronavirusdisease 2019 patientswithcoagulopathy. Journal of ThrombosisandHaemostasis. 2020;18(5):1094-1099.
Google Scholar | Crossref12. Huang, C, Wang, Y, Li, X, et al. Clinicalfeatures of patientsinfectedwith 2019 novelcoronavirus in wuhan, China. Thelancet. 2020;395(10223):497-506.
Google Scholar13. Bellosta, R, Luzzani, L, Natalini, G, et al. Acutelimbischemia in patientswith COVID-19 pneumonia. Journal of VascularSurgery. 2020;72(6):1864–1872.
Google Scholar14. Qian, SZ, Pan, JY. COVID-19 withLimbIschemicnecrosis. Journal of CardiothoracicandVascularAnesthesia. 2020;34(10):2846–2847.
Google Scholar15. Perini, P, Nabulsi, B, Massoni, CB, Azzarone, M, Freyrie, A. Acutelimbischaemia in twoyoung, non-atheroscleroticpatientswith COVID-19. TheLancet. 2020;395(10234):1417–1418.
Google Scholar16. Varga, Z, Flammer, AJ, Steiger, P, et al. Endothelialcellinfectionandendotheliitis in COVID-19. TheLancet. 2020;395:1417-1418.
Google Scholar17. Zhou, F, Yu, T, Du, R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-1062.
Google Scholar | Crossref | Medline18. Leung, JM, Yang, CX, Tam, A, et al. ACE-2 expression in thesmallairwayepithelia of smokersand COPD patients: implicationsfor COVID-19. EuropeanRespiratoryJournal. 2020.
Google Scholar19. Bean, D, Kraljevic, Z, Searle, T, et al. Treatmentwith ACE-inhibitors is associatedwithless severe diseasewith SARS-covid-19 infection in a multi-site UK acuteHospitalTrust. MedRxiv. 2020.
Google Scholar